Literature DB >> 2009915

Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement.

K F Nolan1, W Schwaeble, S Kaluz, M P Dierich, K B Reid.   

Abstract

Northern blot analysis indicated that the mRNA for human properdin is approximately 1.5 kb long and that its level in U-937 cells is increased by pretreating the cells with phorbol 12-myristate 13-acetate (PMA). Using a human genomic probe clones coding for human properdin were isolated from a lambda gt10 cDNA library derived from PMA-treated U-937 cells. The sequence of the 1474-bp cDNA insert of the longest clone revealed an open reading fram of 1326 bp coding for the entire 442 amino acids of the mature form of human properdin and 67 bp coding for 22 amino acids of typical, but incomplete leader sequence. Polymerase chain reaction "RACE" experiments identified the start site ATG and revealed the complete, 27-amino acid-long, leader peptide sequence. Within the 81-bp 3' non-translated extension a polyadenylation signal was identified 41 bp downstream from the stop codon, TAA, and 12 bp upstream of a 19 nucleotide long poly(A) tail. The amino acid sequence of human properdin is clearly divided into three distinct regions: a 49 residue-long N-terminal region, a 32 residue-long C-terminal region and a middle region, covering residues 50 to 411, composed of six tandemly repeated thrombospondin repeat (TSR) motifs of the type first described in the adhesive glycoprotein thrombospondin and also known to be present in the C6, C7, C8 alpha, C8 beta and C9 terminal components of complement. Human and mouse properdin sequences show a high (approximately 76%) degree of identity with almost complete conservation of the relatively large number of Cys (44) and Trp (20) residues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2009915     DOI: 10.1002/eji.1830210333

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Properdin deficiency and meningococcal disease--identifying those most at risk.

Authors:  S M Linton; B P Morgan
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  Localization of the gene cluster encoding the A, B, and C chains of human C1q to 1p34.1-1p36.3.

Authors:  G C Sellar; D Cockburn; K B Reid
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

4.  Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations.

Authors:  G N Fredrikson; B Gullstrand; J Westberg; A G Sjöholm; M Uhlén; L Truedsson
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

Review 5.  The molecular basis of X-linked immunodeficiency disease.

Authors:  C Kinnon; R Levinsky
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Variability and action mechanism of a family of anticomplement proteins in Ixodes ricinus.

Authors:  Bernard Couvreur; Jérôme Beaufays; Cédric Charon; Kathia Lahaye; François Gensale; Valérie Denis; Benoît Charloteaux; Yves Decrem; Pierre-Paul Prévôt; Michel Brossard; Luc Vanhamme; Edmond Godfroid
Journal:  PLoS One       Date:  2008-01-02       Impact factor: 3.240

Review 7.  Properdin: New roles in pattern recognition and target clearance.

Authors:  Claudia Kemper; Dennis E Hourcade
Journal:  Mol Immunol       Date:  2008-08-08       Impact factor: 4.407

8.  The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis.

Authors:  Claudia Kemper; Lynne M Mitchell; Lijuan Zhang; Dennis E Hourcade
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

9.  Cloning and characterization of the cDNA encoding guinea-pig properdin: a comparison of properdin from three species.

Authors:  K K Maves; S T Guenthner; P Densen; D R Moser; J M Weiler
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

Review 10.  Properdin: approaching four decades of research.

Authors:  K K Maves; J M Weiler
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.